OBJECTIVE: To determine whether human immunodeficiency virus (HIV) infection is associated with increased risk of malaria incidence and recurrence in children. METHODS:Newborn infants of HIV-infected mothers were enrolled at 6 weeks and followed for 2 years. HIV status was assessed by enzyme-linked immunosorbant assay and confirmed by HIV DNA polymerase chain reaction. Malaria was defined as (1) physician-diagnosed clinical malaria; (2) probable malaria, in which laboratory testing is requested for parasitemia; and (3) blood smear-confirmed malaria. Cox proportional hazards models estimated hazard ratios (HRs) for development of first and second malaria episodes, and generalized estimating equation models estimated malaria rate differences per 100-child-years in relation to time-updated HIV status. RESULTS:Child HIV infection was associated with clinical (HR, 1.34; 95% confidence interval [CI], 1.12-1.61), probable (HR, 1.47; 95% CI, 1.19-1.81), and confirmed (HR, 1.67; 95% CI, 1.18-2.36) malaria episodes. Per 100 child-years, HIV-infected children experienced 88 (95% CI, 65-113), 36 (95% CI, 19-53), and 20 (95% CI, 9-31) more episodes of clinical, probable, and confirmed malaria episodes, respectively, than HIV-uninfected children. Among children with ≥1 malaria episodes, those with HIV infection developed second clinical (HR, 1.28; 95% CI, 1.04-1.57), probable (HR, 1.60; 95% CI, 1.26-2.14), and confirmed (HR, 2.27; 95% CI, 1.06-3.89) malaria sooner than HIV-uninfected children. CONCLUSIONS: HIV infection is a risk factor for the development of malaria. Proactive malaria disease prevention and treatment is warranted for all children, particularly those with HIV infection in settings of coendemicity.
RCT Entities:
OBJECTIVE: To determine whether human immunodeficiency virus (HIV) infection is associated with increased risk of malaria incidence and recurrence in children. METHODS: Newborn infants of HIV-infected mothers were enrolled at 6 weeks and followed for 2 years. HIV status was assessed by enzyme-linked immunosorbant assay and confirmed by HIV DNA polymerase chain reaction. Malaria was defined as (1) physician-diagnosed clinical malaria; (2) probable malaria, in which laboratory testing is requested for parasitemia; and (3) blood smear-confirmed malaria. Cox proportional hazards models estimated hazard ratios (HRs) for development of first and second malaria episodes, and generalized estimating equation models estimated malaria rate differences per 100-child-years in relation to time-updated HIV status. RESULTS:ChildHIV infection was associated with clinical (HR, 1.34; 95% confidence interval [CI], 1.12-1.61), probable (HR, 1.47; 95% CI, 1.19-1.81), and confirmed (HR, 1.67; 95% CI, 1.18-2.36) malaria episodes. Per 100 child-years, HIV-infectedchildren experienced 88 (95% CI, 65-113), 36 (95% CI, 19-53), and 20 (95% CI, 9-31) more episodes of clinical, probable, and confirmed malaria episodes, respectively, than HIV-uninfectedchildren. Among children with ≥1 malaria episodes, those with HIV infection developed second clinical (HR, 1.28; 95% CI, 1.04-1.57), probable (HR, 1.60; 95% CI, 1.26-2.14), and confirmed (HR, 2.27; 95% CI, 1.06-3.89) malaria sooner than HIV-uninfectedchildren. CONCLUSIONS:HIV infection is a risk factor for the development of malaria. Proactive malaria disease prevention and treatment is warranted for all children, particularly those with HIV infection in settings of coendemicity.
Authors: R Colebunders; Y Bahwe; W Nekwei; R Ryder; J Perriens; K Nsimba; A Turner; H Francis; I Lebughe; P Van der Stuyft Journal: J Infect Date: 1990-09 Impact factor: 6.072
Authors: Moses R Kamya; Anne F Gasasira; Adoke Yeka; Nathan Bakyaita; Samuel L Nsobya; Damon Francis; Philip J Rosenthal; Grant Dorsey; Diane Havlir Journal: J Infect Dis Date: 2005-11-18 Impact factor: 5.226
Authors: I Kalyesubula; P Musoke-Mudido; L Marum; D Bagenda; E Aceng; C Ndugwa; K Olness Journal: Pediatr Infect Dis J Date: 1997-09 Impact factor: 2.129
Authors: Padmaja Patnaik; Charles S Jere; William C Miller; Irving F Hoffman; Jack Wirima; Richard Pendame; Steven R Meshnick; Terrie E Taylor; Malcolm E Molyneux; James G Kublin Journal: J Infect Dis Date: 2005-08-12 Impact factor: 5.226
Authors: Richard O Otieno; Collins Ouma; John M Ong'echa; Christopher C Keller; Tom Were; Eliud N Waindi; Marian G Michaels; Richard D Day; John M Vulule; Douglas J Perkins Journal: AIDS Date: 2006-01-09 Impact factor: 4.177
Authors: Nyanyiwe M Mbeye; Feiko O ter Kuile; Mary-Ann Davies; Kamija S Phiri; Matthias Egger; Gilles Wandeler Journal: Trop Med Int Health Date: 2014-07-08 Impact factor: 2.622
Authors: Mark G Thompson; Robert F Breiman; Mary J Hamel; Meghna Desai; Gideon Emukule; Sammy Khagayi; David K Shay; Kathleen Morales; Simon Kariuki; Godfrey M Bigogo; M Kariuki Njenga; Deron C Burton; Frank Odhiambo; Daniel R Feikin; Kayla F Laserson; Mark A Katz Journal: J Infect Dis Date: 2012-09-14 Impact factor: 5.226
Authors: Robert O Opoka; Karen E S Hamre; Nathan Brand; Paul Bangirana; Richard Idro; Chandy C John Journal: J Pediatric Infect Dis Soc Date: 2017-09-01 Impact factor: 3.164
Authors: Krishanthi Subramaniam; Rebeca M Plank; Nina Lin; Adam Goldman-Yassen; Emil Ivan; Carlos Becerril; Kimdar Kemal; Moonseong Heo; Marla J Keller; Eugene Mutimura; Kathryn Anastos; Johanna P Daily Journal: Open Forum Infect Dis Date: 2014-08-21 Impact factor: 3.835
Authors: Anna Babakhanyan; Gabriel Loni Ekali; Arlene Dent; James Kazura; John Tamo Nguasong; Barriere Airy Yetgang Fodjo; Emile Keming Yuosembom; Livo Forgu Esemu; Diane Wallace Taylor; Rose Gana Fomban Leke Journal: Open Forum Infect Dis Date: 2016-05-10 Impact factor: 3.835